Scientists at the IDIBAPS Biomedical Research Institute and at the Institute for Research in Biomedicine (IRB Barcelona) lead a study in which they have designed a new strategy to get genetically modified viruses to selectively attack tumor cells without affecting healthy tissues. The study, published today by the journal Nature Communications, is part of Eneko Villanueva’s work for his PhD and it is co-lead by Cristina Fillat, head of the Gene Therapy and Cancer Group at IDIBAPS, and Raúl Méndez, ICREA researcher at IRB Barcelona. Read the rest of this entry »
As part of the European WOMEN-UP project, in September the Universitat Politècnica de Catalunya and the Hospital Clínic de Barcelona (Spain), along with the Academic Medical Center (the Netherlands) and Kuopio University Hospital (Finland), will carry out the clinical trial of a system designed to improve pelvic floor muscle training, a recommended treatment to prevent or treat urinary incontinence. This technological solution incorporates serious games for mobile phones that are driven by muscle movement and remote medical monitoring through a web platform. Read the rest of this entry »
The European project LifeBrain will analyze the keys of cognitive ageing with data from more than 6.000 people
The European project LifeBrain has been set up this year. This is a project funded with ten million euros by the European Union program Horizon 2020, and which will last five years, aiming to identify risk and protective factors in the brain and mental health during different life stages. The project counts with the participation of fourteen research groups from different European countries –mainly Scandinavian- coordinated by the University of Oslo. The only group representing southern Europe is led by David Bartrés Faz, researcher from the Institute of Neurosciences of the University of Barcelona and IDIBAPS and coordinator of the Barcelona Brain Stimulaiton Lab (BBSLab). Read the rest of this entry »
The Centre for Genomic Regulation (CRG), the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), the Institute for Research in Biomedicine (IRB Barcelona) and the Vall d’Hebron Research Institute (VHIR) launch the third year of the training programme “PhD for Medical Doctors – PhD4MD”. Read the rest of this entry »
A therapeutic HIV vaccine clinical trial induces viral control in 5 people without taking antiretroviral therapy
A therapeutic HIV vaccine clinical trial showed, for the first time, that in some cases the immune system of HIV infected people can be reeducated to control the virus for long periods without taking antiretroviral treatment. In particular, 5 out of 13 participants who stopped treatment (38.5%) have been controlling the virus for 5, 13, 17, 20 and 27 weeks, respectively. The study, still ongoing, is conducted in Barcelona and tests a vaccine developed by researchers at Oxford University in combination with a drug, romidepsin, able to awaken latent viruses in the body. The study is conducted by IrsiCaixa and the Fight AIDS Foundation and performed at the ospital Clínic de Barcelona-IDIBAPS, the Germans Trias i Pujol University Hospital (Barcelona) and the community center BCN Checkpoint. Read the rest of this entry »
A global partnership, coordinated by the Karolinska Institutet and in which IDIBAPS researchers participate, has received 15 million euros from the European Commission framework program Horizon2020 to find new and improved treatments for Multiple Sclerosis (MS). This project, named MultipleMS, involves universities and companies from 12 European countries and the USA, which will join efforts to adapt the development and application of therapies to each MS patient.